During this course experts will present information on melanoma prevention, risk assessment, early detection, genetic factors, and emerging treatment options.
As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.
After attending this live activity, participants should be able to:
- Demonstrate how newly discovered, evidence-based scientific information applies to the current practice of clinical dermatology.
- Describe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma.
- Examine current data and new strategies for the prevention of melanoma.
- Evaluate and diagnose a variety of malignancies related to melanoma skin cancer.
- Identify possible genetic mutations and etiologic factors in the melanoma patient and diagnose patients based on dermatologic manifestations.
- Incorporate new diagnostic techniques, including dermoscopy, into practice.
- Determine appropriate treatment for patients with metastatic melanoma, melanonychia and ocular melanoma.
- Integrate new therapies and treatments for advanced melanoma including surgical techniques.
- Discuss the effectiveness of neoadjuvant therapy and immunotherapy in treating melanoma.
- Navigate the medico-legal aspects of caring for the melanoma patient.
- Recommend strategies for managing patients with multiple melanomas.
- Provide optimal follow-up of patients after melanoma treatment.
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This course is supported, in part, by educational grants from industry, in accordance with ACCME Accreditation Standards for Commercial Support. Appropriate acknowledgement will be given to all supporters at the time of the educational activity.
Cultural and Linguistic Competency
This activity is in compliance with California Assembly Bill 1195, which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency. The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area. A variety of resources are available that address cultural and linguistic competency, some of which can be found in the Cultural & Linguistic Competency Resource Guide.
Date and time
Sun, Jan 24, 2021 at 12 pm